Xiao Zhu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Topics

Tyrosine Kinase

Quality Control

Ultra High Performance Liquid Chromatography

Top Venues

Molecules (Basel, Switzerland)

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Wenyu Yang, Adam Irwin, Heather Weerdenburg, Brett McWhinney, Theresa Cole, Alice Lei, Bing Han, Xiao Zhu, Amanda Gwee
Serum ganciclovir drug exposure in children receiving standard ganciclovir dosing. Antimicrobial agents and chemotherapy (2024)
Nuo Xu, Yufei Shi, Yixue Wang, Wen Yao Mak, Wenyu Yang, Kar Weng Ng, Yue Wu, Zhijia Tang, Qingfeng He, Gangfeng Yan, Xiao-Qiang Xiang, Xiao Zhu
Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin. Pharmaceutics 16 (6) (2024)
Nuo Xu, Yufei Shi, Yixue Wang, Wen Yao Mak, Wenyu Yang, Kar Weng Ng, Yue Wu, Zhijia Tang, Qingfeng He, Gangfeng Yan, Xiao-Qiang Xiang, Xiao Zhu
Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin. Pharmaceutics 16 (6) (2024)
Yawen Yuan, Zhihong Li, Ke Wang, Shunguo Zhang, Qingfeng He, Lucy Liu, Zhijia Tang, Xiao Zhu, Ying Chen, Weimin Cai, Chao Peng, Xiao-Qiang Xiang
Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Xiwei Ji, Xiangrui Meng, Qingfeng He, Xiao-Qiang Xiang, Yufei Shi, Xiao Zhu
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International journal of molecular sciences 24 (1) (2023)
Yawen Yuan, Zhihong Li, Ke Wang, Shunguo Zhang, Qingfeng He, Lucy Liu, Zhijia Tang, Xiao Zhu, Ying Chen, Weimin Cai, Chao Peng, Xiao-Qiang Xiang
Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Yawen Yuan, Zhihong Li, Ke Wang, Shunguo Zhang, Qingfeng He, Lucy Liu, Zhijia Tang, Xiao Zhu, Ying Chen, Weimin Cai, Chao Peng, Xiao-Qiang Xiang
Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Xiwei Ji, Xiangrui Meng, Qingfeng He, Xiao-Qiang Xiang, Yufei Shi, Xiao Zhu
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International journal of molecular sciences 24 (1) (2023)
Yawen Yuan, Zhihong Li, Ke Wang, Shunguo Zhang, Qingfeng He, Lucy Liu, Zhijia Tang, Xiao Zhu, Ying Chen, Weimin Cai, Chao Peng, Xiao-Qiang Xiang
Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Xiwei Ji, Xiangrui Meng, Qingfeng He, Xiao-Qiang Xiang, Yufei Shi, Xiao Zhu
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International journal of molecular sciences 24 (1) (2023)
Wenyu Yang, Wen Yao Mak, Amanda Gwee, Meng Gu, Yue Wu, Yufei Shi, Qingfeng He, Xiao-Qiang Xiang, Bing Han, Xiao Zhu
Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir. Pharmaceutics 15 (7) (2023)
Liang Yang, Xiao Zhu, David B Finlay, Hayley Green, Michelle Glass, Stephen B Duffull
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid receptor (CB 1 ). British journal of pharmacology (2023)
Yawen Yuan, Zhihong Li, Ke Wang, Shunguo Zhang, Qingfeng He, Lucy Liu, Zhijia Tang, Xiao Zhu, Ying Chen, Weimin Cai, Chao Peng, Xiao-Qiang Xiang
Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Amanda Gwee, Stephen B Duffull, Andrew J Daley, Michelle Lim, Susie Germano, Hajira Bilal, Samantha Hall, Nigel Curtis, Xiao Zhu
Identifying a therapeutic target for vancomycin against staphylococci in young infants. The Journal of antimicrobial chemotherapy 77 (3) (2022)
Zheng Liu, Mette Julsgaard, Xiao Zhu, Jennifer Martin, Murray L Barclay, Noel Cranswick, Peter R Gibson, Richard B Gearry, Janine van der Giessen, Susan J Connor, Ourania Rosella, Anne Grosen, Catherine Toong, Emma K Flanagan, Jantien W Wieringa, C Janneke van der Woude, Sally J Bell, null null
Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children. Journal of Crohn's & colitis 16 (12) (2022)
Jiaying Lin, Min Li, Wen Yao Mak, Yufei Shi, Xiao Zhu, Zhijia Tang, Qingfeng He, Xiao-Qiang Xiang
Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics 10 (12) (2022)
Jiaying Lin, Min Li, Wen Yao Mak, Yufei Shi, Xiao Zhu, Zhijia Tang, Qingfeng He, Xiao-Qiang Xiang
Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics 10 (12) (2022)
Qiuyu Jia, Qingfeng He, Li Yao, Min Li, Jiaying Lin, Zhijia Tang, Xiao Zhu, Xiao-Qiang Xiang
Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Jiaying Lin, Min Li, Wen Yao Mak, Yufei Shi, Xiao Zhu, Zhijia Tang, Qingfeng He, Xiao-Qiang Xiang
Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics 10 (12) (2022)
Qiuyu Jia, Qingfeng He, Li Yao, Min Li, Jiaying Lin, Zhijia Tang, Xiao Zhu, Xiao-Qiang Xiang
Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Qiuyu Jia, Qingfeng He, Li Yao, Min Li, Jiaying Lin, Zhijia Tang, Xiao Zhu, Xiao-Qiang Xiang
Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Jiaying Lin, Min Li, Wen Yao Mak, Yufei Shi, Xiao Zhu, Zhijia Tang, Qingfeng He, Xiao-Qiang Xiang
Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics 10 (12) (2022)
Qiuyu Jia, Qingfeng He, Li Yao, Min Li, Jiaying Lin, Zhijia Tang, Xiao Zhu, Xiao-Qiang Xiang
Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Xiao Zhu, Youyou Tao, Ruilin Zhu, Dezhi Wu, Wai-Kit Ming
Impact of Hospital Characteristics and Governance Structure on the Adoption of Tracking Technologies for Clinical and Supply Chain Use: Longitudinal Study of US Hospitals. Journal of medical Internet research 24 (5) (2022)
Xiao-Qin Liu, Wei-Wei Lin, Chen-Yu Wang, Zi-Ran Li, Xiao Zhu, Zheng Jiao
How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing. Expert review of clinical pharmacology 14 (9) (2021)
Courtney Brusamarello, Andrew J Daley, Xiao Zhu, Cornelia B Landersdorfer, Amanda Gwee
How important are MIC determination methods when targeting vancomycin levels in patients with Staphylococcus aureus infections? The Journal of antimicrobial chemotherapy 76 (6) (2021)
Amanda Gwee, Stephen Duffull, Xiao Zhu, Steven Y C Tong, Noel Cranswick, Brett McWhinney, Jacobus Ungerer, Joshua Francis, Andrew C Steer
Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children. PLoS neglected tropical diseases 14 (12) (2020)
Ricardo Peña-Silva, Stephen B Duffull, Andrew C Steer, Sandra X Jaramillo-Rincon, Amanda Gwee, Xiao Zhu
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19. British journal of clinical pharmacology 87 (3) (2020)
Isabelle H S Kuan, Daniel F B Wright, Stephen B Duffull, Xiao Zhu
Understanding the association between metformin plasma concentrations and lactate. British journal of clinical pharmacology 87 (2) (2020)
Xiao Zhu, David B Finlay, Michelle Glass, Stephen B Duffull
Evaluation of the profiles of CB1 cannabinoid receptor signalling bias using joint kinetic modelling. British journal of pharmacology 177 (15) (2020)
Xiao Zhu, David B Finlay, Michelle Glass, Stephen B Duffull
Model-free and kinetic modelling approaches for characterising non-equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB1 receptors. British journal of pharmacology 176 (14) (2019)
Xiao Zhu, David B Finlay, Michelle Glass, Stephen B Duffull
An intact model for quantifying functional selectivity. Scientific reports 9 (1) (2019)
Xiao Zhu, David B Finlay, Michelle Glass, Stephen B Duffull
An evaluation of the operational model when applied to quantify functional selectivity. British journal of pharmacology 175 (10) (2018)